<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Rapamycin and Trametinib &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/rapamycin-and-trametinib/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 10:32:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Rapamycin and Trametinib &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Extend Your Lifespan: New Insights Revealed</title>
		<link>https://bioengineer.org/extend-your-lifespan-new-insights-revealed/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 28 May 2025 10:20:58 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Age-related disease prevention]]></category>
		<category><![CDATA[Geroprotective drug combination]]></category>
		<category><![CDATA[Lifespan extension]]></category>
		<category><![CDATA[Rapamycin and Trametinib]]></category>
		<category><![CDATA[Synergistic ageing therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/extend-your-lifespan-new-insights-revealed/</guid>

					<description><![CDATA[A groundbreaking study from the Max Planck Institute for Biology of Ageing has unveiled compelling evidence that the combined administration of two cancer drugs, Rapamycin and Trametinib, significantly extends both the lifespan and healthspan of mice. This novel combination therapy exerts a synergistic effect surpassing the benefits observed when either drug is used alone, opening [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">247003</post-id>	</item>
	</channel>
</rss>
